Disease and Economic Burden Averted by Hib Vaccination in 160 Countries: A Machine-Learning Analysis
Hib immunization provide substantial, cost-effective health and economic benefits globally. Persistent inequities in vaccine access for LMICs require targeted solutions. Policymakers in China should consider these findings for future vaccine introduction.
Authors
- S. H. Chan (ORCID: https://orcid.org/0009-0000-7207-6205)
- Wenxi Tang (ORCID: https://orcid.org/0000-0002-3564-3626)
- Jun Wang (ORCID: https://orcid.org/0000-0001-5783-6990)
- Yiyang Gao (ORCID: https://orcid.org/0000-0002-5318-0696)
- Zhehong Xu
- Yuting Xia (ORCID: https://orcid.org/0000-0001-5684-3195)
- Dachuang Zhou
- Yu Wang (ORCID: https://orcid.org/0000-0001-8838-7825)
- Ying Zhong (ORCID: https://orcid.org/0000-0002-8498-1373)
- Di Zhang (ORCID: https://orcid.org/0009-0009-7102-5313)
Institutions
- China Pharmaceutical University (CN)
- Xiamen University (CN)
- Chinese Academy of Sciences (CN)
- Hainan University (CN)
- Institute of Automation (CN)
- Shanghai Institute of Materia Medica (CN)
Publication Details
- Journal
- Vaccines
- Published
- 2025-11-27
- DOI
- https://doi.org/10.3390/vaccines13121197
- Primary Topic
- Bacterial Infections and Vaccines
- Type
- article
- Field-Weighted Citation Impact
- 0.00